Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 May 10;78(1):74–81. doi: 10.1161/HYPERTENSIONAHA.121.17073

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2021 American Heart Association, Inc.

This article is made available via the PMC Open Access Subset for unrestricted re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections.

PMC Copyright notice

Figure 1. — The effect of KBP-5074 on blood pressure in CKD cohort. A) Systolic blood pressure (SBP) from baseline to end of treatment (intent-to-treat [ITT] population/last observation carried forward [LOCF], N=162). P values were calculated based on ANCOVA model. B, Diastolic blood pressure (DBP) from baseline to end of treatment (ITT population/LOCF, N=162).